Dr. Adas Darinskas is a renowned European immuno-oncologist with over 20 years of experience. He is the head scientist and creator behind RBT’s innovative treatments and services.

Reverse Body Time (RBT) is a leading European biotechnology company specializing in regenerative medicine and stem cell therapy. We offer personalized treatments using advanced therapy medicinal products (ATMPs).

Stem Cells (MSC – Mesenchymal Stem Cells): Description: MSCs are multipotent stem cells capable of differentiating into various cell types, including bone, cartilage, and muscle cells. Applications: Used in regenerative therapies to repair and regenerate damaged tissues in conditions such as osteoarthritis, cardiovascular diseases, and tissue injuries. Exosomes: Description: Exosomes are small extracellular vesicles that contain proteins, lipids, and genetic material, facilitating cell communication and tissue repair. Applications: Administered to enhance tissue regeneration and repair, reduce inflammation, and improve recovery outcomes in various medical conditions. Peptides (Including FOXO4): Description: Peptides are short chains of amino acids that regulate biological processes. FOXO4 is known for promoting cellular health and longevity. Applications: Used in anti-aging therapies, tissue repair, and cellular rejuvenation by targeting specific cellular pathways involved in aging and regeneration. Hormones: Description: Hormones are chemical messengers that regulate physiological processes, including growth, metabolism, and immune function. Applications: Hormone therapies correct hormonal imbalances, stimulate tissue repair, and support overall health. Common treatments include testosterone, estragon, and human growth hormone (HGH) therapies. CIK Cells (Cytokine-Induced Killer Cells): Description: CIK cells are immune cells that combine properties of T-cells and natural killer (NK) cells, effectively targeting and eliminating cancer cells. Applications: Used in cancer immunotherapy to enhance the body’s natural immune response against tumours, treating various cancers such as liver cancer, leukaemia, and lymphoma. Gc-MAF (Gc Protein-Derived Macrophage Activating Factor): Description: Gc-MAF is a protein that activates macrophages, crucial immune cells involved in pathogen and cancer cell destruction and tissue repair. Applications: Administered to boost immune function, treat chronic diseases, and support tissue repair in conditions such as chronic fatigue syndrome (CFS) and immune deficiencies. PTCV (Prophylactic Therapeutic Cancer Vaccines): Description: PTCVs are vaccines designed to stimulate the immune system to recognize and destroy cancer cells, preventing recurrence and progression. Applications: Used in cancer prevention for patients at risk of recurrence, enhancing long-term survival and providing a personalized approach to cancer treatment. These products and treatments leverage cutting-edge biotechnological processes and are developed under stringent cGMP standards to ensure the highest quality and efficacy. They are designed to address a wide range of medical conditions, offering innovative solutions in regenerative medicine, anti-aging, immunotherapy, and cancer treatment.

Gc-MAF has been used to treat conditions such as chronic fatigue syndrome (CFS), cancer, and immune deficiencies by boosting the body’s natural defence mechanisms.

CIK cell therapy has shown effectiveness in treating various types of cancer, including liver cancer, leukaemia, and lymphoma, by enhancing the body’s natural immune response to tumours.

Peptide therapy can improve cellular function, enhance tissue repair, reduce inflammation, and slow down aging processes. Specific peptides like FOXO4 target cellular aging mechanisms, promoting overall health and longevity.

PTCVs are formulated from tumour antigens and adjuvants to enhance the immune response, training the body’s immune system to target and eliminate cancer cells.

Hormone therapies include treatments for deficiencies such as low testosterone or estrogen, as well as the use of human growth hormone (HGH) to promote tissue repair and regeneration.

RBT offers a range of treatments including Mesenchymal Stem Cells (MSC), Exosomes, Peptides (including FOXO4), Hormones, Cytokine-Induced Killer (CIK) Cells, Gc-MAF, and Prophylactic Therapeutic Cancer Vaccines (PTCV).

Exosomes are used to promote tissue repair and regeneration. They are administered to patients to enhance the body’s natural healing processes, particularly in conditions such as cardiac repair after myocardial infarction and skin rejuvenation.

FOXO4 is a peptide known for its role in promoting cellular health and longevity by influencing pathways involved in cell survival and apoptosis. It is used in anti-aging therapies to remove senescent cells and improve tissue function.

CIK cell therapy can improve survival rates, reduce tumour size, and provide a targeted approach to cancer treatment with fewer side effects compared to traditional therapies.

Hormone therapy can have side effects, such as hormonal imbalances, and requires careful monitoring by healthcare professionals to ensure safety and effectiveness.

CIK cells are a type of immune cell that combines properties of T-cells and natural killer (NK) cells. They are potent in targeting and eliminating cancer cells without the need for antigen recognition.

Gc-MAF is administered via injection to enhance immune function, helping to clear infections, promote tissue repair, and support overall health in patients with chronic diseases or immune deficiencies.

Peptides are short chains of amino acids that can regulate various biological processes. They are used in treatments to target specific cellular pathways, promoting tissue repair, anti-aging, and other therapeutic effects.

Hormones regulate various physiological processes, including growth, metabolism, and immune function. In regenerative medicine, hormone therapy can correct imbalances, stimulate tissue repair, and support overall health.

Patients who have undergone cancer treatment and are at risk of recurrence can benefit from PTCV therapy, as well as those with high-risk factors for developing cancer.

Peptides can be administered through various routes, including injections, oral tablets, or topical applications, depending on the specific peptide and its intended use.

Peptides like FOXO4 are used to target cellular pathways involved in aging and tissue repair, providing anti-aging benefits and improving overall cell health.

CIK cell therapy involves extracting a patient’s immune cells, activating and expanding them in the lab, and reintroducing them into the patient’s body to target and kill cancer cells.

PTCV therapy is generally safe, but as with any vaccine, there may be risks of mild side effects such as injection site reactions or immune-related symptoms.

Exosome therapy can reduce inflammation, enhance cell survival, and stimulate the regeneration of damaged tissues. It is a non-invasive treatment option with a high potential for improving recovery outcomes.

Exosomes are small extracellular vesicles that facilitate cell communication and promote tissue repair. They are used to enhance regenerative processes in various treatments.

Hormone therapies are typically administered through injections, oral tablets, or topical applications, depending on the specific hormone and its intended use.

Exosome therapy is generally well-tolerated, but as with any medical treatment, there may be risks of mild side effects such as local inflammation or immune reactions. These are typically rare and manageable.

Gc-MAF therapy is generally well-tolerated, but some patients may experience mild side effects such as injection site reactions or flu-like symptoms.

MSCs are used for their regenerative capabilities, helping to repair and regenerate damaged tissues in conditions like osteoarthritis and cardiovascular diseases.

PTCV therapy can reduce the risk of cancer recurrence, enhance long-term survival, and provide a personalized approach to cancer prevention and treatment.

Hormone therapies are used to correct hormonal imbalances, improve metabolic functions, and support regenerative processes in patients.

PTCVs are vaccines designed to prevent cancer recurrence and progression by stimulating the immune system to recognize and destroy cancer cells.

Gc-MAF is a protein that activates macrophages, which are crucial immune cells involved in detecting and destroying pathogens and cancer cells. It also plays a role in tissue repair and regeneration.

Stem cells, particularly mesenchymal stem cells (MSCs), contribute to anti-aging through various mechanisms. Here are the key ways in which stem cells are helping in the anti-aging process: 1. Telomere Maintenance and Extension Mechanism: Stem cells, particularly MSCs, can upregulate telomerase activity, which helps in maintaining and elongating telomeres. Telomeres are protective caps at the ends of chromosomes that shorten with each cell division, and their length is a critical marker of cellular aging. Impact: By preserving telomere length, stem cells help prolong the lifespan of cells and delay the onset of cellular senescence (aging)​​​​. 2. Reduction of Oxidative Stress and Inflammation Mechanism: MSCs secrete various anti-inflammatory agents and antioxidants that reduce oxidative stress and chronic inflammation, both of which are major contributors to the aging process. Impact: Lower oxidative stress and inflammation levels lead to reduced cellular damage and a slower aging process​​​​​​. 3. Enhancement of Mitochondrial Function Mechanism: MSCs can transfer healthy mitochondria to damaged cells, thereby enhancing mitochondrial function. Mitochondria are essential for cellular energy production, and their dysfunction is a hallmark of aging. Impact: Improved mitochondrial function leads to better energy metabolism, reduced metabolic decline, and enhanced cellular vitality​​. 4. Immune System Modulation Mechanism: Stem cells, particularly MSCs, modulate the immune system by secreting cytokines and growth factors that enhance immune function and reduce age-related immune decline. Impact: A more robust immune system can better fight off infections, reduce chronic inflammation, and prevent age-related diseases​​​​. 5. Tissue Repair and Regeneration Mechanism: MSCs promote the repair and regeneration of damaged tissues by differentiating into various cell types and by secreting growth factors and extracellular vesicles that aid in tissue healing. Impact: Enhanced tissue repair and regeneration help maintain the structural and functional integrity of tissues and organs, counteracting age-related degeneration​​​​. 6. Epigenetic Modifications Mechanism: Stem cells can influence epigenetic modifications, such as DNA methylation and histone modification, which play a crucial role in regulating gene expression and aging. Impact: By stabilizing these epigenetic patterns, stem cells help maintain youthful gene expression profiles, which are essential for healthy aging​​. 7. Hormonal Balance Mechanism: Stem cells can influence the secretion of various hormones and peptides that decline with age, including growth factors that regulate cellular functions. Impact: Balanced hormonal levels contribute to improved metabolism, better tissue maintenance, and overall homeostasis, all of which are important for anti-aging​​​​. 8. Prevention of Cellular Senescence Mechanism: MSCs and other types of stem cells can prevent cellular senescence by repairing damaged cells and tissues and by clearing senescent cells through immune modulation. Impact: This leads to a reduction in the accumulation of senescent cells, which are associated with age-related tissue dysfunction and chronic diseases​​​​. In summary, stem cells, particularly MSCs, help in anti-aging by maintaining telomere length, reducing oxidative stress and inflammation, enhancing mitochondrial function, modulating the immune system, promoting tissue repair and regeneration, influencing epigenetic modifications, balancing hormonal levels, and preventing cellular senescence. These combined effects contribute to slowing down the aging process and improving overall health and longevity​​​​.

Stem cells, despite their significant potential and promising results in various medical fields, are not as widely known or utilized due to several factors: 1. Complexity of the Science Explanation: The science behind stem cells is complex and highly specialized. Understanding how stem cells work, their mechanisms of action, and their potential applications require advanced scientific and medical knowledge. Impact: This complexity can make it challenging for the general public to grasp the significance and potential of stem cell therapies, leading to a lack of widespread awareness. 2. Regulatory and Ethical Issues Explanation: Stem cell research, particularly involving embryonic stem cells, has been subject to significant ethical and regulatory scrutiny. Concerns about the moral implications of using human embryos for research have led to stringent regulations and restrictions in many countries. Impact: These regulatory hurdles slow down research progress and limit public awareness and acceptance of stem cell therapies. 3. Cost and Accessibility Explanation: Stem cell treatments can be expensive, often involving advanced medical procedures and technologies that are not widely available. Impact: High costs and limited accessibility mean that these treatments are not commonly discussed or experienced by the general population, contributing to their lower profile. 4. Research and Development Stage Explanation: Many stem cell therapies are still in the experimental or clinical trial stages. It takes considerable time to move from laboratory research to widespread clinical use, with many treatments still undergoing rigorous testing for safety and efficacy. Impact: The focus on ongoing research rather than established treatments means that stem cells are less likely to be part of mainstream medical discussions. 5. Public Perception and Misconceptions Explanation: There are various misconceptions and a lack of understanding about what stem cells are and how they can be used. Media reports sometimes focus on the controversies rather than the scientific advances. Impact: Misleading information and sensationalism can lead to public scepticism or misunderstanding about the real benefits and limitations of stem cell therapies. 6. Lack of Public Education and Advocacy Explanation: There has been relatively limited public education on stem cell science compared to other medical advancements. Advocacy and educational efforts by scientists and medical professionals are crucial to raising awareness. Impact: Without concerted efforts to educate the public and policymakers, awareness and understanding of stem cell therapies remain low. 7. Slow Integration into Standard Medical Practice Explanation: Integrating new treatments into standard medical practice takes time, requiring extensive validation through clinical trials and the development of standardized protocols. Impact: Until stem cell therapies become part of routine medical practice, they will remain less known to the general public. 8. Scientific and Technical Challenges Explanation: There are significant scientific and technical challenges in stem cell research, including issues related to cell sourcing, differentiation, and ensuring the safety and efficacy of treatments. Impact: These challenges can delay the development and adoption of stem cell therapies, keeping them out of the public eye. 9. Limited Marketing and Commercialization Explanation: Stem cell therapies are often developed by research institutions and smaller biotech companies rather than large pharmaceutical companies. This can result in limited marketing and public exposure. Impact: Without widespread marketing efforts, the general public remains less informed about the potential of stem cell treatments. Conclusion Stem cells hold great promise for regenerative medicine and anti-aging therapies, but various factors, including scientific complexity, regulatory and ethical issues, cost, ongoing research stages, public misconceptions, lack of education, integration challenges, technical difficulties, and limited commercialization, contribute to their lower profile and awareness among the general public. Addressing these barriers through education, advocacy, and continued research is crucial to increasing awareness and acceptance of stem cell therapies.

Stem cell therapy, particularly using mesenchymal stem cells (MSCs), can influence various aging biomarkers. The primary biomarkers and mechanisms affected by stem cell therapy include: Telomere Length and Telomerase Activity: Stem cell therapy has been shown to enhance telomerase activity and elongate telomeres, which are crucial markers of cellular aging. This helps in prolonging the lifespan of cells and delaying senescence​​​​. Oxidative Stress and Inflammation: MSCs and other stem cell therapies help reduce oxidative stress and inflammation, which are major contributors to aging. They secrete anti-inflammatory agents and antioxidant factors that help mitigate the effects of chronic inflammation and oxidative damage​​​​​​. Mitochondrial Function: Stem cell therapy improves mitochondrial function and energy regulation. MSCs, for instance, can transfer healthy mitochondria to damaged cells, enhancing cellular metabolism and reducing the metabolic decline associated with aging​​. Immune System Modulation: MSCs can modulate the immune system, restoring its function and improving its response to aging-related decline. This involves the secretion of various cytokines and growth factors that support immune health and reduce the risk of age-related diseases​​​​. Tissue Regeneration and Healing: MSCs promote tissue repair and regeneration by secreting growth factors and extracellular vesicles that aid in the healing of damaged tissues. This contributes to maintaining the structural and functional integrity of tissues and organs, countering age-related degeneration​​​​. Epigenetic Changes: Epigenetic modifications, such as DNA methylation patterns, are influenced by stem cell therapy. MSCs can help in stabilizing these patterns, which play a crucial role in the aging process and the development of age-related diseases​​. Hormonal Balance: Stem cell therapy can impact hormonal regulation, particularly in balancing levels of growth factors and other signalling molecules that decline with age. This includes peptides and hormones that play roles in growth, metabolism, and overall homeostasis​​​​. In summary, stem cell therapy, particularly with MSCs, affects various biomarkers of aging by enhancing telomere length, reducing oxidative stress and inflammation, improving mitochondrial function, modulating the immune system, promoting tissue regeneration, influencing epigenetic changes, and balancing hormonal levels. These effects collectively contribute to the anti-aging benefits of stem cell therapy​​​​.

RBT provides regular updates through newsletters, training sessions, and collaborative meetings to keep partners informed about new developments.

RBT is actively engaged in pioneering research, clinical trials, and collaborations with leading research institutions to advance regenerative medicine.

1. Adherence to Good Manufacturing Practices (cGMP): cGMP Compliance: All RBT products are manufactured in facilities that adhere to current Good Manufacturing Practices (cGMP). This ensures the highest standards of product quality, safety, and consistency in production processes. Regular Audits: Facilities undergo regular internal and external audits to ensure ongoing compliance with cGMP standards. 2. Certification and Accreditation: ISO Certifications: RBT’s manufacturing and research facilities are certified with ISO 9001 (Quality Management Systems) and ISO 13485 (Medical Devices – Quality Management Systems). FDA Registration: Our facilities are registered with the U.S. Food and Drug Administration (FDA), ensuring compliance with stringent regulatory requirements. 3. Regulatory Approvals and Clinical Trials: IRB Approval: All clinical trials and research activities are approved by Institutional Review Boards (IRB) to ensure ethical and scientific integrity. Regulatory Submissions: RBT submits detailed documentation to relevant regulatory authorities (e.g., EMA in Europe, TGA in Australia, FDA in the USA) for approval of new treatments and clinical trials. 4. Quality Control and Assurance: Batch Testing: Each batch of products undergoes rigorous testing for purity, potency, and absence of contaminants. This includes sterility tests, endotoxin tests, and assays for specific activity. Validation Protocols: Production processes are validated to ensure they consistently produce products meeting predetermined specifications and quality attributes. 5. Documentation and Record Keeping: Comprehensive Documentation: Detailed documentation is maintained for all production processes, quality control tests, and clinical trial data. This ensures traceability and accountability. Compliance Reports: Regular reports are generated to demonstrate compliance with local and international regulatory requirements. 6. Ethical Standards and Patient Safety: Informed Consent: Patients are provided with comprehensive information about the treatments, including potential risks and benefits, and informed consent is obtained prior to participation. Patient Monitoring: Continuous monitoring of patients during and after treatment to ensure safety and efficacy, with all adverse events documented and reported as required. 7. Research and Development Practices: Ethical Research: All research activities comply with international ethical guidelines and local regulations. This includes adherence to the Declaration of Helsinki and Good Clinical Practice (GCP) guidelines. Collaborations: Collaboration with accredited research institutions and compliance with their regulatory standards to ensure the highest quality of scientific research. 8. Environmental and Safety Regulations: Environmental Compliance: RBT adheres to environmental regulations related to waste disposal, emissions, and sustainable practices. Workplace Safety: Compliance with occupational health and safety regulations to ensure a safe working environment for all employees. 9. Training and Education: Continuous Training: Regular training programs for staff on regulatory requirements, quality control procedures, and safety protocols. Regulatory Updates: Staying updated with changes in local and international regulations to ensure ongoing compliance. 10. International Market Adaptation: – Market-Specific Compliance: Adapting products and documentation to meet the specific regulatory requirements of each international market RBT enters. – Global Standards: Ensuring that all products meet or exceed global standards for quality, safety, and efficacy, facilitating smoother regulatory approvals across different regions. By rigorously adhering to these practices and standards, RBT ensures that all products comply with both local and international regulatory requirements, providing assurance of quality and safety to patients, healthcare providers, and regulatory bodies worldwide.

RBT’s facilities are certified with ISO 9001, ISO 13485, ensuring the highest standards of production and quality control.

RBT’s facilities are certified with ISO 9001, ISO 13485, ensuring the highest standards of production and quality control.

Rigorous Clinical Trials: Design and Execution: All treatments undergo extensive clinical trials designed to evaluate their safety and efficacy. These trials follow strict protocols and are conducted under the supervision of regulatory bodies. Phases: Trials are conducted in multiple phases (I, II, III, and IV) to progressively assess safety, optimal dosing, effectiveness, and long-term effects. 2. Compliance with Regulatory Standards: cGMP Compliance: All manufacturing processes adhere to current Good Manufacturing Practices (cGMP) to ensure the highest standards of product quality and safety. Certifications: Facilities are certified with ISO 9001 and ISO 13485 standards, and registered with the FDA, ensuring compliance with international regulatory requirements. 3. Quality Control and Assurance: Stringent Testing: Each batch of products undergoes rigorous testing for purity, potency, and absence of contaminants. Validation: Procedures for isolation, expansion, and processing of cells and other biological materials are validated to ensure consistency and safety. 4. Real-Time Monitoring and Data Collection: During Treatment: Patients are closely monitored during treatment for any adverse reactions or side effects. Vital signs and other relevant parameters are continuously assessed. Post-Treatment: Follow-up appointments are scheduled to monitor patient recovery and treatment efficacy over time. 5. Advanced Diagnostic Tools: Imaging and Biomarkers: Use of advanced diagnostic tools such as imaging and biomarker analysis to track treatment progress and outcomes. Data Analytics: Leveraging data analytics to interpret clinical data and make informed decisions about treatment adjustments if necessary. 6. Patient Follow-Up and Support: Regular Check-Ins: Structured follow-up schedule with regular check-ins (e.g., every three months for 24 months post-treatment) to assess long-term safety and efficacy. Support Services: Providing comprehensive patient support services to address any concerns and ensure adherence to post-treatment care plans. 7. Adverse Event Reporting: Systematic Reporting: Robust system for reporting and managing any adverse events or side effects, ensuring immediate attention and mitigation. Review and Action: Regular review of reported events to identify patterns and take corrective actions to improve treatment protocols. 8. Collaboration with Healthcare Providers: Integrated Care: Collaboration with primary healthcare providers to ensure a holistic approach to patient care. Education and Training: Continuous education and training for healthcare providers on the latest treatment protocols and safety measures. 9. Ethical Oversight: IRB Approval: All clinical trials and treatments are approved by Institutional Review Boards (IRB) to ensure ethical standards are maintained. Ethical Practices: Commitment to ethical practices in all aspects of patient care and research. 10. Patient Education: – Informed Consent: Ensuring patients are fully informed about the potential risks and benefits of treatments through comprehensive consent processes. – Educational Materials: Providing patients with detailed information and educational materials about their treatments. By implementing these robust measures, RBT ensures that patient safety and treatment efficacy are continuously monitored and maintained at the highest standards, providing confidence and trust in our innovative therapies.

The process involves a thorough medical evaluation, personalized treatment planning, and administration of the therapy at our state-of-the-art clinics.

RBT offers comprehensive training programs, marketing materials, and ongoing support to ensure the successful integration and administration of our treatments.

1. Regulatory and Compliance: Licensing: The clinic must hold all necessary licenses and certifications required by local health authorities to operate and offer advanced medical treatments. Regulatory Approval: Obtain approval from relevant regulatory bodies for offering RBT’s treatments, ensuring compliance with local laws and regulations. Ethical Standards: Adherence to ethical guidelines and standards, including patient consent and data protection laws. 2. Facility Standards: Infrastructure: The clinic should have appropriate facilities, including sterile treatment rooms and advanced medical equipment, to safely administer RBT’s therapies. Storage Capabilities: Adequate storage conditions, such as temperature-controlled environments, to maintain the integrity of biological products like stem cells, exosomes, and peptides. Safety Protocols: Implementation of strict safety and hygiene protocols to prevent contamination and ensure patient safety. 3. Staff Qualifications and Training: Qualified Personnel: The clinic must employ healthcare professionals with relevant qualifications and experience in administering regenerative and advanced therapies. Training Programs: Participation in RBT’s comprehensive training programs to ensure staff are proficient in administering treatments, handling products, and following protocols. Continuing Education: Commitment to ongoing education and training to stay updated with the latest advancements and best practices in regenerative medicine. 4. Equipment and Technology: Medical Equipment: Access to advanced medical equipment necessary for administering treatments, such as infusion pumps for exosomes and CIK cells, and imaging devices for monitoring treatment progress. Diagnostic Tools: Availability of diagnostic tools to evaluate patient conditions and tailor treatments accordingly. IT Systems: Implementation of secure IT systems to manage patient data, treatment records, and communication with RBT. 5. Patient Management and Care: Patient Evaluation: Ability to conduct thorough patient evaluations to determine suitability for RBT’s treatments, including medical history reviews and diagnostic tests. Informed Consent: Processes in place to ensure patients are fully informed about the treatments, including potential risks and benefits, and provide informed consent. Follow-Up Care: Capability to provide comprehensive follow-up care, including regular monitoring of treatment progress and managing any side effects or complications. 6. Partnership Agreement: Contractual Agreement: Enter into a formal partnership agreement with RBT, outlining the terms and conditions of offering RBT’s treatments, including pricing, training, support, and compliance requirements. Commitment to Standards: Agreement to adhere to RBT’s standards for treatment administration, patient care, and quality control. 7. Marketing and Patient Outreach: Marketing Plan: Development of a marketing plan to promote RBT’s treatments to potential patients, leveraging RBT’s branding and marketing materials. Patient Education: Providing educational resources to patients to help them understand the benefits and potential outcomes of RBT’s treatments. 8. Data and Reporting: Data Collection: Implement systems to collect and report patient data, treatment outcomes, and any adverse events to RBT for ongoing evaluation and improvement. Regular Reporting: Commitment to regular reporting and communication with RBT to ensure transparency and continuous quality improvement. By meeting these requirements, clinics can ensure they are well-prepared to offer RBT’s advanced therapies, providing high-quality care to their patients and contributing to the overall success and reputation of RBT’s treatments.

All products are produced in cGMP-compliant facilities, undergo rigorous quality control, and are tested for purity, potency, and safety.

RBT offers various models including agent-based roles, B2B supply arrangements, and exclusive local ambassadorships.

Partners benefit from exclusive product access, comprehensive support, marketing materials, and the opportunity to be at the forefront of regenerative medicine.

1. NAD+ (Nicotinamide Adenine Dinucleotide) Testing What is NAD+? NAD+ is a coenzyme found in every cell in the body, crucial for energy production, DNA repair, and maintaining healthy metabolism. It declines with age, which is thought to contribute to aging processes and a decline in cellular function. How is NAD+ related to aging? NAD+ supports the activity of sirtuins, proteins involved in longevity, and helps repair DNA. Reduced levels of NAD+ are associated with cellular aging, decreased energy, and cognitive decline. Testing Method: Blood tests can measure NAD+ levels to assess cellular energy metabolism and aging markers. The test results help in crafting personalised anti-aging treatments. Sample Requirement: Typically, a blood sample is required. Turnaround Time (TAT): Results are usually available within a week, depending on the lab. Use in Therapy: Based on NAD+ levels, treatments often include NAD+ supplements or NAD+-boosting peptides like MOTS-c to restore cellular energy and slow down aging. 2. SASP (Senescence-Associated Secretory Phenotype) Testing What is SASP? SASP refers to the inflammatory factors released by senescent cells (cells that have stopped dividing but remain in the body). These cells contribute to aging and chronic diseases by promoting inflammation. How does SASP impact health? SASP-related inflammation is linked to age-related diseases like cardiovascular disease, diabetes, and neurodegenerative disorders. Reducing SASP activity is a key target for anti-aging interventions. Testing Method: SASP testing involves measuring pro-inflammatory cytokines, chemokines, and growth factors in blood or tissue samples. These markers indicate the presence and activity of senescent cells. Sample Requirement: Blood or tissue biopsy may be required, depending on the specific SASP markers being measured. Turnaround Time (TAT): Testing results typically take 1-2 weeks. Use in Therapy: SASP inhibition therapies, like senolytic drugs or certain peptides (such as FOXO4), target the reduction of senescent cells and their inflammatory output, potentially reversing some aspects of aging. 3. Telomere Testing What are Telomeres? Telomeres are protective caps at the ends of chromosomes that shorten as cells divide. Short telomeres are associated with cellular aging, reduced regenerative capacity, and increased risk of age-related diseases. How does telomere length affect health? Short telomeres are a marker of biological aging. Telomere testing is used to estimate an individual’s biological age compared to their chronological age. Testing Method: Telomere length is measured through blood tests, using techniques such as quantitative PCR (qPCR) to determine the average length of telomeres in white blood cells. Sample Requirement: Blood sample is commonly required. Turnaround Time (TAT): Results can take 1-2 weeks. Use in Therapy: Based on telomere length results, treatments like telomerase-activating peptides (such as Epithalon) can be used to potentially lengthen telomeres and slow down cellular aging​​​.

1. Comprehensive Closed-Loop System: Integration: RBT integrates research and development, manufacturing, and clinical services into a seamless closed-loop system. This allows for direct delivery of treatments from the lab to the patient without intermediaries, ensuring higher efficiency and control over quality. 2. Advanced Technological Capabilities: Cutting-Edge Technologies: Utilizes the latest advancements in biotechnology, including state-of-the-art production techniques and diagnostic tools, to develop and deliver innovative treatments. Proprietary Methods: Employs proprietary technologies and patented processes for the production of stem cells, exosomes, peptides, and other therapeutic products. 3. Diverse Range of Therapies: Wide Spectrum: Offers a comprehensive range of therapies, including Mesenchymal Stem Cells (MSC), Exosomes, Peptides (including FOXO4), Hormones, Cytokine-Induced Killer (CIK) Cells, Gc-MAF, and Prophylactic Therapeutic Cancer Vaccines (PTCV). Personalized Treatments: Focuses on personalized medicine, tailoring treatments to individual patient needs for more effective outcomes. 4. High Standards of Quality and Safety: cGMP Compliance: All products are manufactured in facilities that comply with current Good Manufacturing Practices (cGMP), ensuring the highest standards of quality and safety. ISO Certification: Facilities are ISO 9001 and ISO 13485 certified, reflecting adherence to stringent quality management systems. 5. Regulatory Excellence: Global Compliance: Ensures compliance with local and international regulatory standards, including FDA registration and EMA guidelines. Ethical Practices: Adheres to ethical guidelines in all aspects of treatment development and delivery, including informed patient consent and rigorous clinical trial protocols. 6. Renowned Leadership and Expertise: Dr. Adas Darinskas: Led by Dr. Adas Darinskas, a renowned European immuno-oncologist with over 20 years of experience in regenerative medicine, providing a strong foundation of scientific and clinical expertise. Experienced Team: Comprises highly qualified biomedical doctors, molecular biologists, and biotechnologists dedicated to advancing regenerative medicine. 7. Comprehensive Support and Training: Partner Support: Provides extensive training programs, marketing materials, and ongoing support to partner clinics and agents, ensuring successful integration and administration of treatments. Patient Education: Offers comprehensive educational resources to patients, helping them understand the benefits and potential outcomes of treatments. 8. Research and Development Focus: Innovative Research: Continuously invests in cutting-edge research to develop new and more effective treatments, with findings published in peer-reviewed journals. Collaborative Projects: Actively collaborates with leading research institutions, universities, and biotechnology companies globally. 9. Global Expansion and Reach: International Presence: Actively expanding into key international markets, including the UK, Switzerland, Australia, Canada, and the USA, among others. Localized Expertise: Establishes partnerships with local agents and clinics to ensure treatments are adapted to regional needs and regulatory environments. 10. Patient-Centric Approach: – Holistic Care: Emphasizes a holistic approach to patient care, integrating personalized treatment plans with comprehensive follow-up and support. – Long-Term Outcomes: Focuses on achieving long-term positive outcomes for patients, ensuring sustained health benefits and improved quality of life.